温阳复元方联合西药治疗缺血性中风恢复期患者109例临床观察

发布时间：2018-04-27 13:17

本文选题：缺血性中风恢复期 + 温阳复元方　；参考：《中医杂志》2017年18期

【摘要】：目的观察温阳复元方治疗缺血性中风恢复期的临床疗效。方法将3家医院入选的缺血性中风恢复期患者230例分为治疗组和对照组各115例。两组均予以西医基础治疗,在此基础上治疗组给予口服温阳复元方,对照组给予口服补阳还五汤,每日1剂。治疗28天后,观察两组临床疗效以及治疗前后神经功能缺损评分、日常生活活动能力评分、中医主要症状总积分。结果治疗组完成研究109例,对照组完成研究106例。治疗组临床疗效总有效率为90.8%,对照组为76.4%,治疗组优于对照组(P0.05)。治疗后两组患者的神经功能缺损评分及中医主要症状总积分均明显降低,日常生活活动能力评分明显升高(P0.05或P0.01);治疗组治疗后神经功能缺损评分及中医主要症状总积分低于对照组,日常生活活动能力评分明显高于对照组(P0.05)。结论温阳复元方可以明显提高缺血性中风恢复期患者临床疗效,改善临床症状及神经功能,疗效优于补阳还五汤。
[Abstract]:Objective to observe the clinical effect of Wenyang Fuyuan recipe on ischemic apoplexy in convalescence. Methods 230 patients with ischemic stroke in convalescence were divided into treatment group (115 cases) and control group (115 cases). Both groups were treated with basic western medicine, and the treatment group was given oral Wenyang Fuyuan decoction, while the control group was given oral buyang Huanwu decoction, 1 dose per day. After 28 days of treatment, the clinical efficacy, neurological deficit score, activity of daily living score, total score of main symptoms of TCM were observed. Results 109 cases were completed in the treatment group and 106 cases in the control group. The total effective rate of the treatment group was 90.8 and that of the control group was 76.4.The treatment group was superior to the control group (P 0.05). After treatment, the neurological deficit score and the total score of the main symptoms of TCM were significantly decreased in the two groups. The scores of ADL were significantly higher than that of control group (P0.05 or P0.01), the scores of neurological deficit and main symptoms of TCM in treatment group were lower than those in control group, and the score of ADL was significantly higher than that of control group (P0.05). Conclusion Wenyang Fuyuan prescription can obviously improve the clinical effect, improve clinical symptoms and nerve function of patients with ischemic stroke in recovery stage, and the curative effect is better than Buyang Huanwu decoction.
【作者单位】：广西中医药大学第一附属医院;广西中医药大学;广西中医药大学附属瑞康医院;南宁市中医院;
【基金】：广西科学研究与技术开发计划(桂科攻1598012-44) 广西医疗卫生适宜技术研究与开发项目(S201533,S201677)
【分类号】：R743.3

【相似文献】